|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
3/28/2013
|
FRIEDMAN PAUL A
|
Director
|
433
|
$17.29
|
7.28%
|
|
3/28/2013
|
CLASSON ROLF A
|
Director
|
541
|
$17.29
|
3.34%
|
|
2/7/2013
|
Tursi James Patrick
|
Chief Medical Officer
|
-426
|
$18.30
|
-2.19%
|
|
2/7/2013
|
KOVEN ANDREW I
|
EVP, CAO, GC and Secretary
|
-910
|
$18.30
|
-3.81%
|
|
2/7/2013
|
WILLS ALAN
|
EVP, Corporate Development
|
-426
|
$18.30
|
-1.47%
|
|
2/7/2013
|
Fickenscher James E
|
Chief Financial Officer
|
-482
|
$18.30
|
-1.05%
|
|
2/7/2013
|
DEL TITO BENJAMIN J JR
|
EVP, Reg Affairs & Project Mgt
|
-333
|
$18.30
|
-2.43%
|
|
2/7/2013
|
Glickman Mark A
|
EVP - Sales and Marketing
|
-426
|
$18.30
|
-2.16%
|
|
2/3/2013
|
Glickman Mark A
|
EVP - Sales and Marketing
|
-398
|
$18.85
|
-13.27%
|
|
12/31/2012
|
CLASSON ROLF A
|
Director
|
404
|
$18.54
|
2.56%
|
|
12/31/2012
|
FETZER OLIVER
|
Director
|
214
|
$18.54
|
1.97%
|
|
12/31/2012
|
FRIEDMAN PAUL A
|
Director
|
404
|
$18.54
|
5.05%
|
|
10/25/2012
|
WILLS ALAN
|
EVP, Corporate Development
|
-826
|
$21.01
|
-7.74%
|
|
9/28/2012
|
FRIEDMAN PAUL A
|
Director
|
306
|
$24.46
|
3.98%
|
|
9/28/2012
|
FETZER OLIVER
|
Director
|
163
|
$24.46
|
1.52%
|
|
9/28/2012
|
CLASSON ROLF A
|
Director
|
306
|
$24.46
|
1.98%
|
|
6/29/2012
|
Lurker Nancy
|
Director
|
417
|
$26.89
|
5.95%
|
|
6/29/2012
|
FRIEDMAN PAUL A
|
Director
|
231
|
$26.89
|
3.10%
|
|
6/29/2012
|
CLASSON ROLF A
|
Director
|
220
|
$26.89
|
1.44%
|
|
6/29/2012
|
FETZER OLIVER
|
Director
|
120
|
$26.89
|
1.13%
|
|
6/25/2012
|
DEL TITO BENJAMIN J JR
|
EVP, Reg Affairs & Project Mgt
|
-12,682
|
$25.01
|
-73.94%
|
|
6/25/2012
|
DEL TITO BENJAMIN J JR
|
EVP, Reg Affairs & Project Mgt
|
12,682
|
$5.50
|
283.71%
|
|
6/6/2012
|
DEL TITO BENJAMIN J JR
|
EVP, Reg Affairs & Project Mgt
|
-300
|
$22.55
|
-3.74%
|
|
6/6/2012
|
DEL TITO BENJAMIN J JR
|
EVP, Reg Affairs & Project Mgt
|
-5,700
|
$22.55
|
-73.80%
|
|
6/6/2012
|
DEL TITO BENJAMIN J JR
|
EVP, Reg Affairs & Project Mgt
|
6,000
|
$9.15
|
296.44%
|
|
3/30/2012
|
Lurker Nancy
|
Director
|
605
|
$18.57
|
42.97%
|
|
3/30/2012
|
FRIEDMAN PAUL A
|
Director
|
336
|
$18.57
|
15.86%
|
|
3/30/2012
|
FETZER OLIVER
|
Director
|
174
|
$18.57
|
3.21%
|
|
3/30/2012
|
CLASSON ROLF A
|
Director
|
319
|
$18.57
|
3.21%
|
|
3/30/2012
|
FUCHS RENATO
|
Director
|
150
|
$18.57
|
9.07%
|
|
2/28/2012
|
Fickenscher James E
|
Chief Financial Officer
|
-1,053
|
$20.07
|
-3.92%
|
|
2/28/2012
|
Brandt Peter C.
|
Director
|
9,700
|
$20.10
|
3,233.33%
|
|
1/5/2012
|
CLASSON ROLF A
|
Director
|
118
|
$19.05
|
1.20%
|
|
1/5/2012
|
FETZER OLIVER
|
Director
|
141
|
$19.05
|
2.67%
|
|
1/5/2012
|
FRIEDMAN PAUL A
|
Director
|
236
|
$19.05
|
12.54%
|
|
12/30/2011
|
CLASSON ROLF A
|
Director
|
297
|
$19.93
|
3.12%
|
|
12/30/2011
|
Lurker Nancy
|
Director
|
563
|
$19.93
|
66.63%
|
|
12/30/2011
|
FUCHS RENATO
|
Director
|
140
|
$19.93
|
9.25%
|
|
12/30/2011
|
FRIEDMAN PAUL A
|
Director
|
312
|
$19.93
|
19.87%
|
|
12/30/2011
|
FETZER OLIVER
|
Director
|
244
|
$19.93
|
4.84%
|
|
11/3/2011
|
Fickenscher James E
|
Chief Financial Officer
|
1,610
|
$15.54
|
6.38%
|
|
10/25/2011
|
WILLS ALAN
|
EVP, Corporate Development
|
-826
|
$15.98
|
-8.26%
|
|
10/7/2011
|
ANIDO ARMANDO
|
CEO & President
|
-5,275
|
$14.23
|
-27.87%
|
|
10/7/2011
|
ANIDO ARMANDO
|
CEO & President
|
5,275
|
$7.81
|
38.64%
|
|
9/30/2011
|
CLASSON ROLF A
|
Director
|
545
|
$14.99
|
6.08%
|
|
9/30/2011
|
FETZER OLIVER
|
Director
|
325
|
$14.99
|
6.89%
|
|
9/30/2011
|
FUCHS RENATO
|
Director
|
186
|
$14.99
|
14.02%
|
|
9/30/2011
|
FRIEDMAN PAUL A
|
Director
|
416
|
$14.99
|
36.05%
|
|
9/30/2011
|
Lurker Nancy
|
Director
|
750
|
$14.99
|
789.47%
|
|
8/2/2011
|
14159 capital (GP), LLC
|
TenPercent
|
-1,001
|
$17.25
|
-0.75%
|
|
8/2/2011
|
Baker Biotech Capital (GP), LLC
|
TenPercent
|
-6,361
|
$17.25
|
-0.75%
|
|
8/2/2011
|
Baker Brothers Life Sciences Capital (GP), LLC
|
TenPercent
|
-40,781
|
$17.25
|
-0.75%
|
|
8/2/2011
|
Baker / Tisch Capital (GP), LLC
|
TenPercent
|
-507
|
$17.25
|
-0.75%
|
|
8/1/2011
|
Baker / Tisch Capital (GP), LLC
|
TenPercent
|
-3,243
|
$18.03
|
-4.27%
|
|
8/1/2011
|
Baker Brothers Life Sciences Capital (GP), LLC
|
TenPercent
|
-394,404
|
$18.04
|
-6.74%
|
|
8/1/2011
|
Baker / Tisch Capital (GP), LLC
|
TenPercent
|
-4,902
|
$18.04
|
-6.74%
|
|
8/1/2011
|
14159 capital (GP), LLC
|
TenPercent
|
-6,400
|
$18.03
|
-4.27%
|
|
8/1/2011
|
14159 capital (GP), LLC
|
TenPercent
|
-9,678
|
$18.04
|
-6.74%
|
|
8/1/2011
|
Baker Biotech Capital (GP), LLC
|
TenPercent
|
-40,690
|
$18.03
|
-4.27%
|
|
8/1/2011
|
Baker Biotech Capital (GP), LLC
|
TenPercent
|
-61,519
|
$18.04
|
-6.74%
|
|
8/1/2011
|
Baker Brothers Life Sciences Capital (GP), LLC
|
TenPercent
|
-260,868
|
$18.03
|
-4.27%
|
|
7/8/2011
|
ANIDO ARMANDO
|
CEO & President
|
-5,275
|
$20.30
|
-27.87%
|
|
7/8/2011
|
ANIDO ARMANDO
|
CEO & President
|
5,275
|
$7.81
|
38.64%
|
|
6/30/2011
|
CLASSON ROLF A
|
Director
|
354
|
$19.60
|
4.11%
|
|
6/30/2011
|
FRIEDMAN PAUL A
|
Director
|
318
|
$19.60
|
38.04%
|
|
6/30/2011
|
FUCHS RENATO
|
Director
|
142
|
$19.60
|
11.98%
|
|
6/30/2011
|
FETZER OLIVER
|
Director
|
248
|
$19.60
|
5.55%
|
|
5/23/2011
|
Chambon Philippe O.
|
Director
|
-21,726
|
$21.77
|
-74.20%
|
|
5/11/2011
|
Chambon Philippe O.
|
Director
|
-718,858
|
$23.00
|
-96.09%
|
|
3/31/2011
|
CLASSON ROLF A
|
Director
|
290
|
$21.47
|
3.49%
|
|
3/31/2011
|
FRIEDMAN PAUL A
|
Director
|
290
|
$21.47
|
53.11%
|
|
3/31/2011
|
Chambon Philippe O.
|
Senior Executive Officer
|
697
|
$21.47
|
0.09%
|
|
3/31/2011
|
FUCHS RENATO
|
Director
|
130
|
$21.47
|
12.32%
|
|
3/31/2011
|
FUCHS RENATO
|
Director
|
261
|
$21.47
|
24.74%
|
|
3/31/2011
|
FRIEDMAN PAUL A
|
Director
|
145
|
$21.47
|
26.56%
|
|
3/31/2011
|
FETZER OLIVER
|
Director
|
226
|
$21.47
|
5.33%
|
|
3/31/2011
|
CLASSON ROLF A
|
Director
|
1,164
|
$21.47
|
13.99%
|
|
3/31/2011
|
Chambon Philippe O.
|
Senior Executive Officer
|
174
|
$21.47
|
0.02%
|
|
3/30/2011
|
14159 capital (GP), LLC
|
TenPercent
|
3,911
|
$21.98
|
2.68%
|
|
3/30/2011
|
Baker Bros. Capital (GP), LLC
|
TenPercent
|
309
|
$21.98
|
4.62%
|
|
3/29/2011
|
Baker Brothers Life Sciences Capital (GP), LLC
|
TenPercent
|
82,000
|
$21.94
|
1.36%
|
|
3/29/2011
|
Baker Brothers Life Sciences Capital (GP), LLC
|
TenPercent
|
250,000
|
$22.00
|
4.33%
|
|
3/19/2011
|
Graham Roger D Jr
|
EVP, Sales & Marketing
|
-1,806
|
$22.26
|
-9.30%
|
|
3/9/2011
|
Baker Brothers Life Sciences Capital (GP), LLC
|
TenPercent
|
550,000
|
$22.75
|
10.53%
|
|
3/9/2011
|
Baker Brothers Life Sciences Capital (GP), LLC
|
TenPercent
|
115,000
|
$23.44
|
2.25%
|
|
3/9/2011
|
Baker Brothers Life Sciences Capital (GP), LLC
|
TenPercent
|
117,273
|
$23.17
|
2.35%
|
|
3/8/2011
|
14159 capital (GP), LLC
|
TenPercent
|
304
|
$23.05
|
0.22%
|
|
3/8/2011
|
14159 capital (GP), LLC
|
TenPercent
|
1,343
|
$22.86
|
0.94%
|
|
3/8/2011
|
14159 capital (GP), LLC
|
TenPercent
|
2,380
|
$22.88
|
1.69%
|
|
3/8/2011
|
14159 capital (GP), LLC
|
TenPercent
|
1,612
|
$22.81
|
1.12%
|
|
3/8/2011
|
14159 capital (GP), LLC
|
TenPercent
|
54
|
$22.51
|
0.04%
|
|
3/8/2011
|
Baker Brothers Life Sciences Capital (GP), LLC
|
TenPercent
|
86,227
|
$22.88
|
1.80%
|
|
3/8/2011
|
Baker Brothers Life Sciences Capital (GP), LLC
|
TenPercent
|
10,996
|
$23.05
|
0.23%
|
|
3/8/2011
|
Baker Brothers Life Sciences Capital (GP), LLC
|
TenPercent
|
48,657
|
$22.86
|
1.00%
|
|
3/8/2011
|
ANIDO ARMANDO
|
CEO & President
|
-5,280
|
$23.01
|
-27.89%
|
|
3/8/2011
|
Baker Brothers Life Sciences Capital (GP), LLC
|
TenPercent
|
1,948
|
$22.51
|
0.04%
|
|
3/8/2011
|
ANIDO ARMANDO
|
CEO & President
|
5,280
|
$7.81
|
38.67%
|
|
3/8/2011
|
Baker Brothers Life Sciences Capital (GP), LLC
|
TenPercent
|
58,388
|
$22.81
|
1.18%
|
|
3/8/2011
|
ANIDO ARMANDO
|
CEO & President
|
5,275
|
$7.81
|
38.64%
|
|
3/8/2011
|
CHAMBON PHILIPPE
|
Director
|
-718,858
|
$22.76
|
-49.03%
|